Detailed TOC of Biodefense - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2033
1 Market Overview
1.1 Biodefense Product Introduction
1.2 Global Biodefense Market Size Forecast
1.3 Biodefense Market Trends & Drivers
1.3.1 Biodefense Industry Trends
1.3.2 Biodefense Market Drivers & Opportunity
1.3.3 Biodefense Market Challenges
1.3.4 Biodefense Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biodefense Players Revenue Ranking (2023)
2.2 Global Biodefense Revenue by Company (2019-2025)
2.3 Key Companies Biodefense Manufacturing Base Distribution and Headquarters
2.4 Key Companies Biodefense Product Offered
2.5 Key Companies Time to Begin Mass Production of Biodefense
2.6 Biodefense Market Competitive Analysis
2.6.1 Biodefense Market Concentration Rate (2019-2025)
2.6.2 Global 5 and 10 Largest Companies by Biodefense Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Anthrax
3.1.2 Smallpox
3.1.3 Botulism
3.1.4 Radiation/Nuclear
3.1.5 Others
3.2 Global Biodefense Sales Value by Type
3.2.1 Global Biodefense Sales Value by Type (2019 VS 2023 VS 2033)
3.2.2 Global Biodefense Sales Value, by Type (2019-2033)
3.2.3 Global Biodefense Sales Value, by Type (%) (2019-2033)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 US Military Market
4.1.2 US Civilian Market
4.1.3 Non - US Market
4.2 Global Biodefense Sales Value by Application
4.2.1 Global Biodefense Sales Value by Application (2019 VS 2023 VS 2033)
4.2.2 Global Biodefense Sales Value, by Application (2019-2033)
4.2.3 Global Biodefense Sales Value, by Application (%) (2019-2033)
5 Segmentation by Region
5.1 Global Biodefense Sales Value by Region
5.1.1 Global Biodefense Sales Value by Region: 2019 VS 2023 VS 2033
5.1.2 Global Biodefense Sales Value by Region (2019-2025)
5.1.3 Global Biodefense Sales Value by Region (2025-2033)
5.1.4 Global Biodefense Sales Value by Region (%), (2019-2033)
5.2 North America
5.2.1 North America Biodefense Sales Value, 2019-2033
5.2.2 North America Biodefense Sales Value by Country (%), 2023 VS 2033
5.3 Europe
5.3.1 Europe Biodefense Sales Value, 2019-2033
5.3.2 Europe Biodefense Sales Value by Country (%), 2023 VS 2033
5.4 Asia Pacific
5.4.1 Asia Pacific Biodefense Sales Value, 2019-2033
5.4.2 Asia Pacific Biodefense Sales Value by Country (%), 2023 VS 2033
5.5 South America
5.5.1 South America Biodefense Sales Value, 2019-2033
5.5.2 South America Biodefense Sales Value by Country (%), 2023 VS 2033
5.6 Middle East & Africa
5.6.1 Middle East & Africa Biodefense Sales Value, 2019-2033
5.6.2 Middle East & Africa Biodefense Sales Value by Country (%), 2023 VS 2033
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biodefense Sales Value Growth Trends, 2019 VS 2023 VS 2033
6.2 Key Countries/Regions Biodefense Sales Value
6.3 United States
6.3.1 United States Biodefense Sales Value, 2019-2033
6.3.2 United States Biodefense Sales Value by Type (%), 2023 VS 2033
6.3.3 United States Biodefense Sales Value by Application, 2023 VS 2033
6.4 Europe
6.4.1 Europe Biodefense Sales Value, 2019-2033
6.4.2 Europe Biodefense Sales Value by Type (%), 2023 VS 2033
6.4.3 Europe Biodefense Sales Value by Application, 2023 VS 2033
6.5 China
6.5.1 China Biodefense Sales Value, 2019-2033
6.5.2 China Biodefense Sales Value by Type (%), 2023 VS 2033
6.5.3 China Biodefense Sales Value by Application, 2023 VS 2033
6.6 Japan
6.6.1 Japan Biodefense Sales Value, 2019-2033
6.6.2 Japan Biodefense Sales Value by Type (%), 2023 VS 2033
6.6.3 Japan Biodefense Sales Value by Application, 2023 VS 2033
6.7 South Korea
6.7.1 South Korea Biodefense Sales Value, 2019-2033
6.7.2 South Korea Biodefense Sales Value by Type (%), 2023 VS 2033
6.7.3 South Korea Biodefense Sales Value by Application, 2023 VS 2033
6.8 Southeast Asia
6.8.1 Southeast Asia Biodefense Sales Value, 2019-2033
6.8.2 Southeast Asia Biodefense Sales Value by Type (%), 2023 VS 2033
6.8.3 Southeast Asia Biodefense Sales Value by Application, 2023 VS 2033
6.9 India
6.9.1 India Biodefense Sales Value, 2019-2033
6.9.2 India Biodefense Sales Value by Type (%), 2023 VS 2033
6.9.3 India Biodefense Sales Value by Application, 2023 VS 2033
7 Company Profiles
7.1 Emergent Biosolutions
7.1.1 Emergent Biosolutions Profile
7.1.2 Emergent Biosolutions Main Business
7.1.3 Emergent Biosolutions Biodefense Products, Services and Solutions
7.1.4 Emergent Biosolutions Biodefense Revenue (US$ Million) & (2019-2025)
7.1.5 Emergent Biosolutions Recent Developments
7.2 Hytest
7.2.1 Hytest Profile
7.2.2 Hytest Main Business
7.2.3 Hytest Biodefense Products, Services and Solutions
7.2.4 Hytest Biodefense Revenue (US$ Million) & (2019-2025)
7.2.5 Hytest Recent Developments
7.3 GSK
7.3.1 GSK Profile
7.3.2 GSK Main Business
7.3.3 GSK Biodefense Products, Services and Solutions
7.3.4 GSK Biodefense Revenue (US$ Million) & (2019-2025)
7.3.5 Sanofi Recent Developments
7.4 Sanofi
7.4.1 Sanofi Profile
7.4.2 Sanofi Main Business
7.4.3 Sanofi Biodefense Products, Services and Solutions
7.4.4 Sanofi Biodefense Revenue (US$ Million) & (2019-2025)
7.4.5 Sanofi Recent Developments
7.5 PharmAthene
7.5.1 PharmAthene Profile
7.5.2 PharmAthene Main Business
7.5.3 PharmAthene Biodefense Products, Services and Solutions
7.5.4 PharmAthene Biodefense Revenue (US$ Million) & (2019-2025)
7.5.5 PharmAthene Recent Developments
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Profile
7.6.2 Bavarian Nordic Main Business
7.6.3 Bavarian Nordic Biodefense Products, Services and Solutions
7.6.4 Bavarian Nordic Biodefense Revenue (US$ Million) & (2019-2025)
7.6.5 Bavarian Nordic Recent Developments
7.7 SIGA Technologies
7.7.1 SIGA Technologies Profile
7.7.2 SIGA Technologies Main Business
7.7.3 SIGA Technologies Biodefense Products, Services and Solutions
7.7.4 SIGA Technologies Biodefense Revenue (US$ Million) & (2019-2025)
7.7.5 SIGA Technologies Recent Developments
7.8 Arbutus Biopharma
7.8.1 Arbutus Biopharma Profile
7.8.2 Arbutus Biopharma Main Business
7.8.3 Arbutus Biopharma Biodefense Products, Services and Solutions
7.8.4 Arbutus Biopharma Biodefense Revenue (US$ Million) & (2019-2025)
7.8.5 Arbutus Biopharma Recent Developments
7.9 DynPort Vaccine
7.9.1 DynPort Vaccine Profile
7.9.2 DynPort Vaccine Main Business
7.9.3 DynPort Vaccine Biodefense Products, Services and Solutions
7.9.4 DynPort Vaccine Biodefense Revenue (US$ Million) & (2019-2025)
7.9.5 DynPort Vaccine Recent Developments
7.10 Xoma Corporation
7.10.1 Xoma Corporation Profile
7.10.2 Xoma Corporation Main Business
7.10.3 Xoma Corporation Biodefense Products, Services and Solutions
7.10.4 Xoma Corporation Biodefense Revenue (US$ Million) & (2019-2025)
7.10.5 Xoma Corporation Recent Developments
7.11 Ichor Medical Systems
7.11.1 Ichor Medical Systems Profile
7.11.2 Ichor Medical Systems Main Business
7.11.3 Ichor Medical Systems Biodefense Products, Services and Solutions
7.11.4 Ichor Medical Systems Biodefense Revenue (US$ Million) & (2019-2025)
7.11.5 Ichor Medical Systems Recent Developments
7.12 Aeolus Pharmaceuticals
7.12.1 Aeolus Pharmaceuticals Profile
7.12.2 Aeolus Pharmaceuticals Main Business
7.12.3 Aeolus Pharmaceuticals Biodefense Products, Services and Solutions
7.12.4 Aeolus Pharmaceuticals Biodefense Revenue (US$ Million) & (2019-2025)
7.12.5 Aeolus Pharmaceuticals Recent Developments
7.13 Achaogen
7.13.1 Achaogen Profile
7.13.2 Achaogen Main Business
7.13.3 Achaogen Biodefense Products, Services and Solutions
7.13.4 Achaogen Biodefense Revenue (US$ Million) & (2019-2025)
7.13.5 Achaogen Recent Developments
7.14 Elusys Therapeutics
7.14.1 Elusys Therapeutics Profile
7.14.2 Elusys Therapeutics Main Business
7.14.3 Elusys Therapeutics Biodefense Products, Services and Solutions
7.14.4 Elusys Therapeutics Biodefense Revenue (US$ Million) & (2019-2025)
7.14.5 Elusys Therapeutics Recent Developments
7.15 Dynavax Technologies
7.15.1 Dynavax Technologies Profile
7.15.2 Dynavax Technologies Main Business
7.15.3 Dynavax Technologies Biodefense Products, Services and Solutions
7.15.4 Dynavax Technologies Biodefense Revenue (US$ Million) & (2019-2025)
7.15.5 Dynavax Technologies Recent Developments
7.16 Cleveland BioLabs
7.16.1 Cleveland BioLabs Profile
7.16.2 Cleveland BioLabs Main Business
7.16.3 Cleveland BioLabs Biodefense Products, Services and Solutions
7.16.4 Cleveland BioLabs Biodefense Revenue (US$ Million) & (2019-2025)
7.16.5 Cleveland BioLabs Recent Developments
7.17 Soligenix
7.17.1 Soligenix Profile
7.17.2 Soligenix Main Business
7.17.3 Soligenix Biodefense Products, Services and Solutions
7.17.4 Soligenix Biodefense Revenue (US$ Million) & (2019-2025)
7.17.5 Soligenix Recent Developments
7.18 Alnylam Pharmaceuticals
7.18.1 Alnylam Pharmaceuticals Profile
7.18.2 Alnylam Pharmaceuticals Main Business
7.18.3 Alnylam Pharmaceuticals Biodefense Products, Services and Solutions
7.18.4 Alnylam Pharmaceuticals Biodefense Revenue (US$ Million) & (2019-2025)
7.18.5 Alnylam Pharmaceuticals Recent Developments
8 Industry Chain Analysis
8.1 Biodefense Industrial Chain
8.2 Biodefense Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Biodefense Sales Model
8.5.2 Sales Channel
8.5.3 Biodefense Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Download FREE Sample Report
